Eledon Pharmaceuticals, Inc. Cash Equivalents, at Carrying Value
Eledon Pharmaceuticals, Inc. (ELDN) had Cash Equivalents, at Carrying Value of $9.40 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2023-05-11
- 2023-03-31: Cash Equivalents, at Carrying Value $9.40M.
- 2022-12-31: Cash Equivalents, at Carrying Value $9.30M.
- 2022-09-30: Cash Equivalents, at Carrying Value $9.20M.
- 2022-06-30: Cash Equivalents, at Carrying Value $9.20M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2023-03-31 | $9.40M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $9.30M 10-Q · filed 2023-05-11 | |
| 2022-09-30 | $9.20M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $9.20M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $9.20M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $9.30M 10-K · filed 2023-03-30 | $9.20M 10-K · filed 2022-03-24 |
| 2021-09-30 | $9.20M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $9.20M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $9.20M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $9.20M 10-K · filed 2022-03-24 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-17 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-28 | |
| 2016-12-31 | $531.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |